International commission examines conflicting evidence on health effects of blue light exposure

FHS
March 5, 2024
12:57 pm

For years, scientists have expressed concern about potential adverse health effects of excessive exposure to short wavelength light (SWL), which includes the “blue light” from smartphones, laptops, and tablets.

Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder | Psychedelic Invest

TORONTO, November 18, 2024–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company“), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing

November 18, 2024

U.K. pharma increasingly violates voluntary industry marketing codes, and probes are taking longer

Pharmaceutical companies in the U.K. have increasingly violated a voluntary industry marketing code but complaints are also taking longer to review, according to a new

June 25, 2024

Ex-Celgene chief Mark Alles, former Goldfinch Bio leader Tony Johnson are back in the game as CEOs

→ For the first time since he sold Celgene to Bristol Myers Squibb for $74 billion in 2019, Mark Alles is a CEO again. Alles

January 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.